medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2010, Number 02

<< Back Next >>

Ginecol Obstet Mex 2010; 78 (02)

Prevalence of condyloma acuminata in women who went to opportune detection of cervicouterine cancer

Jiménez-Vieyra CR
Full text How to cite this article

Language: Spanish
References: 9
Page: 99-102
PDF size: 308.73 Kb.


Key words:

Condyloma acuminata, cervical cancer.

ABSTRACT

Background: It has been considered the incidence and the prevalence of the disease of sexual transmission with base in the different data banks. Unfortunately, each of these sources has limitations.
Objective: To evaluate annual prevalence of genital condiloma acuminate in the women who go to opportune detection of cervicouterino cancer.
Material and method: Study realized in a first level of attention, the Zaragoza clinic of the System of Collective Transport Metro of Mexico City; of January of the year 2000 to June of year 2009. All the patients included themselves in the study that went to opportune detection of cervicouterino cancer.
Results: 3,232 cervicovaginal cytologist were realized of which 106 cases presented condylomata acuminata genital confirmed by clinic and biopsy, settling down an annual prevalence of 3.2%; the prevalence by ages the greater number of cases appear between the 30 and 34 years with rate of 21.6%.
Discussion: The prevalence of the infection by human virus papailoma varies in the different regions from the world; usually they reach from 20 to 30% in the women of 20 to 24 years of age and falls later to 3 to 10% in the women majors of 30 years.
Conclusion: It is important to establish measures of prevention directed to prevent the contagion, exhorting to the adolescent population men and women to have a responsible sexuality.


REFERENCES

  1. Garfias R, Villareal C, Juárez A. Conceptos actuales sobre infección por virus del papiloma humano. Ginecol Obstet Mex 1995;63:509-512.

  2. Ferenczy A. Epidemiology and clinical pathophysiology of condyloma acuminata. Am J Obstet Gynecol 1995;172:1331-1339.

  3. Casanova RG, Ortiz IF, Reyna F. Infecciones de transmisión sexual, virus papiloma humano. Sección II. Cap. 5. México: Alfil, 2004;pp:49-69.

  4. Gounter J. Genital and perineal warts: New treatment opportunities for human papiloma virus infection. Am J Obstet Gynecol 2003;189:S3-S11.

  5. Blackledge D, Rusell R. “HPV effect” in the female lower genital tract. J Reprod Medic 1998;43:929-932.

  6. Heim K, Widschwendter A, Szedenik H, et al. Specific serologic response to genital human papilomavirus types in patients with vulvar precancerous and cancerous lesions. Am J Obstet Gynec 2005;192:1073-1083.

  7. Bai H, Cviko A, Granter S, et al. Immunophenotypic and viral (human papiloma virus) correlates of vulvar seborrheic keratosis. Human Pathology 2003;34:559-564.

  8. Taner Z, Taskiran C, Onan A, et al. Therapeutic value of trichloroacetic acid in the treatment of isolated genital warts on the external female genitalia. J Reprod Medic 2007;52:521-525.

  9. Hu D, Goldie S. The economic burden of noncervical human papilomavirus disease in the United States. Am J Obstet Gynecol 2008;198:500-502.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2010;78